Danone SA (BSND) Stock Price & Analysis
BSND Stock Chart & Stats
- Day’s Range
- EUR 13.20 - EUR 13.20
- 52-Week Range
- EUR 11.10 - EUR 15.90
- Previous Close
- EUR 13.40
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 43.10B
- Enterprise Value
- EUR 63.02B
- Total Cash (Recent Filing)
- EUR 8.34B
- Total Debt (Recent Filing)
- EUR 17.42B
- Price to Earnings (P/E)
- 22.0
- Beta
- 0.09
- Next Earnings
- Feb 24, 2027 (Est.)
- EPS Estimate
- 0.41
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 3.33%
Bulls Say, Bears Say
Bulls Say
Broad Organic Growth
Broad-based organic growth across regions and categories indicates improving demand for Danone’s portfolio rather than reliance on one market. Reaffirmed full-year guidance also supports revenue visibility, while positive volume-mix contributions suggest growth is not driven solely by pricing.
Health-Focused Portfolio
Specialized and medical nutrition provide exposure to health-oriented demand and higher-value products, supporting portfolio quality. Faster growth in hospitals, pharmacies, home care, and away-from-home channels can broaden distribution and reduce reliance on conventional mass retail.
Resilient Profitability And Cash Flow
Stable operating profitability combined with positive free cash flow demonstrates that Danone continues converting sales into internally generated funds. Margin improvement despite commodity and recall headwinds supports ongoing investment in brands, innovation, productivity, and portfolio development.
Bears Say
Weak Recent Revenue Trend
The longer-term flat-to-down revenue pattern shows that recent improvement has not yet fully established a durable growth record. Weak underlying top-line momentum can limit operating leverage, reduce reinvestment capacity, and make sustained earnings expansion more dependent on pricing or productivity.
Moderate Debt-Cash Coverage
Danone generates positive free cash flow, but softer 2025 cash-flow momentum and modest operating-cash-flow coverage of debt indicate only reasonable deleveraging capacity. This can constrain financial flexibility for acquisitions, shareholder returns, or investment if operating conditions weaken.
North America EDP Constraints
Competitiveness problems and insufficient yogurt capacity can limit Danone’s ability to capture demand in an important developed market. Although additional lines are expected through H2 and 2027, the transition may prolong portfolio underperformance and delay margin recovery.
Danone SA News
BSND FAQ
What was Danone SA’s price range in the past 12 months?
What is Danone SA’s market cap?
When is Danone SA’s upcoming earnings report date?
How were Danone SA’s earnings last quarter?
Is Danone SA overvalued?
Does Danone SA pay dividends?
What is Danone SA’s EPS estimate?
How many shares outstanding does Danone SA have?
What happened to Danone SA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Danone SA?
What is the TipRanks Smart Score and how is it calculated?
Danone SA Stock Smart Score
Company Description
Danone SA
Danone S.A. is a leading global enterprise in the food and beverage industry, with extensive operations spanning Europe, North America, Latin America, the Asia Pacific region, Africa, and the Middle East. The company's business is structured around three core segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Its Essential Dairy & Plant-Based segment encompasses a diverse portfolio of offerings, including yogurts, milk products, coffee creamers, various drinks and beverages, plant-based alternatives, ice creams, desserts, and nutritional powdered protein products. These are marketed under well-known proprietary brands such as Actimel, Activia, Alpro, and Danonino, as well as licensed brands like International Delight, Dunkin' Donuts, and Bailey's. The Specialized Nutrition division focuses on health-oriented products. This includes nutritional solutions for expectant and lactating mothers, infants, and young children, featuring brands like Aptamil, Nutrilon, and Happy Family Organics. Furthermore, it supplies clinical nutrition items such as tube feeding formulas (e.g., Nutrison) and oral nutritional supplements (e.g., Fortimel, NutriDrink). For children with allergies, Danone provides specialized hypoallergenic products under names like Aptamil ProSyneo and Neocate Syneo. Its Waters segment delivers a range of bottled waters, including natural mineral waters, those infused with fruit extracts, fruit juices, and vitamins, from popular brands such as evian, Volvic, Aqua, and Bonafont. Distribution of Danone's products occurs via a comprehensive multi-channel network, encompassing major retail chains, local market outlets, convenience stores, and specialized healthcare settings like hospitals, clinics, and pharmacies. The company also leverages e-commerce platforms to reach consumers. Founded in 1899, the company, originally known as Groupe Danone, adopted its current name, Danone S.A., in April 2009. Its corporate headquarters are located in Paris, France.
- Sector
- Consumerdefensive
- Industry
- Packaged Foods
- CEO
- Antoine Bernard de Saint-Affrique
- Employees
- 88,670
- Website
- www.danone.com
- Address
- 59-61 rue La Fayette, Paris, IF, 75009, FR
Danone SA (BSND) Earnings & Revenues
BSND Company Deck
BSND Earnings Call
Earnings Call SentimentPositive
The call presented a predominantly constructive picture: broad‑based organic growth across regions and categories, modest margin improvement at group level (+12 bps) and solid cash generation (EUR 0.9bn), alongside active M&A that enhances the health‑focused portfolio. These positives were tempered by legacy IMF recall effects, localized competitiveness issues in North America EDP (capacity constraints), timing‑related EDP margin pressure from inflation versus pricing, an intentional inventory build (~EUR 250m) that temporarily reduced near‑term free cash flow, and currency/refinancing headwinds. Management reiterated FY guidance and outlined concrete remediation and investment plans, signaling confidence in the recovery trajectory.
View all DE:BSND earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 16 | 2 | 4 |
| Technical Analysis | 4 | 2 | 4 |
| Moving Averages | 12 | 0 | 0 |
